GlassScriptPhysician profile
Dipa S Patel
NPI 1205836962
$3,702.90
in general payments reported to CMS, 2019-2025
27 companies · $637 in 2025
The $637 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $77.78 · 2021: $416 · 2022: $922 · 2023: $943 · 2024: $440 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,919.93 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $373.31 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $353.68 | 2019-2025 | Ilumya, Odomzo, Blu-U |
| Regeneron Healthcare Solutions, INC. | $331.58 | 2021-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $325.31 | 2022-2025 | Sotyktu |
| Abbvie INC. | $318.42 | 2019-2025 | |
| Amgen INC. | $282.41 | 2021-2025 | Otezla, Otezla, Enbrel |
| Pfizer INC. | $252.47 | 2019-2025 | |
| Incyte Corporation | $251.40 | 2022-2024 | Opzelura |
| Merz North America, INC. | $212.06 | 2022 | |
| Janssen Biotech, INC. | $169.67 | 2019-2023 | Simponi, Stelara, Simponi Aria |
| Lilly USA, LLC | $115.49 | 2019-2024 | Taltz, Olumiant, Ebglyss |
| Arcutis Biotherapeutics, INC. | $100.05 | 2023-2025 | Zoryve |
| Ucb, INC. | $92.89 | 2019-2022 | |
| Biofrontera INC. | $87.11 | 2019-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Novartis Pharmaceuticals Corporation | $79.41 | 2019-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $58.61 | 2020-2022 | |
| Strata Skin Sciences, INC. | $50.69 | 2021-2022 | |
| Dermira, INC. | $41.98 | 2019 | |
| Journey Medical Corporation | $39.60 | 2023-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.38 | 2021-2022 | |
| Galderma Laboratories, L.P. | $29.41 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.20 | 2023 | Cyltezo |
| Paratek Pharmaceuticals, INC. | $19.09 | 2021 | |
| Organogenesis INC. | $15.11 | 2023 | Puraply |
| Mayne Pharma Commercial LLC | $14.71 | 2019 | |
| Dermavant Sciences, INC. | $14.59 | 2023 | Vtama |
| Promius Pharma LLC | $14.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.